Financial News
Latest News about AZN
Recent news which mentions AZN
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
From InvestorPlace
Hopes that children will soon be eligible for Pfizer and BioNTech vaccine cheer parents, and Biden pushes vaccine requirements in Chicago
October 07, 2021
From MarketWatch
What Do Mix-and-Match Doses Mean for Vaccine Stocks?
October 07, 2021
From Motley Fool
Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year
October 06, 2021
From MarketWatch
Is This The Turning Point for Inovio?
October 06, 2021
From Motley Fool
Why Novavax Sank by Nearly 5% on Tuesday
October 05, 2021
From Motley Fool
Ocugen Bulls Are Overlooking Its FDA Approval Hurdles
October 05, 2021
From InvestorPlace
Positive news on COVID-19 vaccines and treatments in the U.S. weighs against Russia’s latest record one-day death toll
October 05, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
From Benzinga
Bank of America turns bearish on European stocks, sees ‘anti-goldilocks’ shift ahead
October 01, 2021
Tickers
AZN
From MarketWatch
EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
September 30, 2021
From Benzinga
AstraZeneca vaccine shows 74% efficacy in large U.S.-backed trial, and BioNTech co-founder says COVID will become manageable
September 30, 2021
From MarketWatch
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
September 29, 2021
From Benzinga
Why AstraZeneca And Pfizer Shares Are Moving Today
September 29, 2021
From Benzinga
AstraZeneca and ASML lead European stocks on a rebound after Wall-Street induced rout
September 29, 2021
From MarketWatch
Can These Former Biotech Growth Stocks Regain Their Form?
September 29, 2021
From Motley Fool
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
September 29, 2021
From Benzinga
AstraZeneca Buys Fortress-Biotech Founded Caelum For $500M
September 29, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
Does This Biotech Have the Secret to Conquering Covid Variants?
September 29, 2021
From Motley Fool
AstraZeneca's Saphnelo For Lupus Treatment Approved In Japan
September 28, 2021
From Benzinga
AstraZeneca, Sputnik Light COVID-19 Vaccine Mix Shows Strong Antibody Growth: Reuters
September 27, 2021
From Benzinga
Novavax and the Changing Covid-19 Vaccine Game
September 27, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
